DGKZ and osteosarcoma: These results suggest a potential interaction between DGKZ and ERK1/2-MYC pathway might play an important role in promotion of osteosarcoma, indicating that interfering with function or expression of this interaction may be a potential route to block the invasiveness of osteosarcoma.